David C Linehan

6PUBLICATIONS
75CO-AUTHORS
Molecular targetsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 05, 2024
Pan-lysyl oxidase inhibition disrupts fibroinflammatory tumor stroma, rendering cholangiocarcinoma susceptible to chemotherapy.

Paul R Burchard, Luis I Ruffolo, Nicholas A Ullman

|Dec 02, 2022
Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and Extensive Intratumoral Heterogeneity.

Hannah L Williams, Andressa Dias Costa, Jinming Zhang

|Sep 21, 2022
Neoadjuvant Chemotherapy Is Associated with Altered Immune Cell Infiltration and an Anti-Tumorigenic Microenvironment in Resected Pancreatic Cancer.

Andressa Dias Costa, Sara A Väyrynen, Akhil Chawla

|Jul 15, 2022
Immunologic Strategies in Pancreatic Cancer: Making Cold Tumors Hot.

Nicholas A Ullman, Paul R Burchard, Richard F Dunne

|Apr 27, 2021
HE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Immune Microenvironment and Enhanced Tumor and Macrophage PD-L1 Expression.

Rachael B Rowswell-Turner, Rakesh K Singh, Anze Urh

|Jun 25, 2020
The clonal evolution of metastatic colorectal cancer.

Ha X Dang, Bradley A Krasnick, Brian S White

Pageof 1

Frequent Collaborators

3 joint publications

Richard F Dunne

2 joint publications

Andressa Dias Costa

2 joint publications

Chen Yuan

2 joint publications

Juha P Väyrynen